T1	Participants 39 83	patients with isolated hypertriglyceridemia.
T2	Participants 348 392	patients with isolated hypertriglyceridemia.
T3	Participants 420 567	39 patients with elevated triglyceride levels and peripheral artery sclerosis, treated for 90 days with either simvastatin (40 mg daily) or placebo
T4	Participants 1240 1299	fibrinolysis in patients with isolated hypertriglyceridemia
T5	Participants 1339 1393	benefits to patients with elevated triglyceride levels
